Pharmacy
How to Verify a Pharmacy Now That the Shortage Rules Have Changed
Pharmacy verification mattered during the compounding era because no premarket FDA review stood behind the product. It matters more now, because any seller still supplying compounded tirzepatide is operating under a contested legal theory. The checks are the same and they remain independently verifiable: legal name, state licence, facility type, concentration, and beyond-use dating.
Key takeaways
- Any seller still offering compounded tirzepatide warrants more scrutiny, not less.
- Pharmacy legal name and state licence are checkable against public board registers.
- 503B claims are checkable against the FDA outsourcing facility list.
- Concentration and beyond-use dating should be stated before purchase.
- No consumer check substitutes for the premarket review approved products undergo.
| Checkable independently | Legal name, state licence, 503A/503B status, disciplinary history |
|---|---|
| Should be disclosed pre-purchase | Concentration in mg/mL, beyond-use date policy |
| Where to check licences | The licensing state board of pharmacy register |
| Where to check 503B claims | The FDA outsourcing facility list |
| Verified in our dataset | None — pharmacy fields are pending for all 24 providers |
Why does verification matter more now?
Because the legal footing changed. During the shortage, compounded tirzepatide was supplied under an explicit statutory exemption, and the question was whether a given pharmacy operated well. Now the exemption has lapsed, and any continued supply rests on an argument that the preparation is not essentially a copy — a position the FDA has contested.
A pharmacy operating on that basis may still be well run. But the buyer is now assessing both quality and legal standing, and only the first was ever visible to consumers.
| Check | How to do it | What a gap tells you |
|---|---|---|
| Pharmacy legal name | Ask in writing before enrolling | Refusal withholds the single most useful fact |
| State licence number | Search the licensing board's public register | Unlisted or lapsed is disqualifying |
| 503A or 503B status | Ask, then check the FDA 503B list for 503B claims | A 503B claim absent from the list is a serious discrepancy |
| Disciplinary history | State board records and enforcement notices | Not automatically disqualifying but material |
| Concentration in mg/mL | Ask before ordering; confirm on the label | Without it, safe use is impossible |
| Beyond-use date policy | Ask what date is assigned and on what basis | No policy suggests weak quality systems |
| Cold-chain policy | Ask who bears risk for a warm shipment | No policy means the risk is yours |
| Group | Consumer checks establish | Remains unverified |
|---|---|---|
| Pharmacy is authorised to operate | 10 | 0 |
| Facility type is as claimed | 9 | 0 |
| Preparation quality for your vial | 2 | 8 |
| Premarket safety and efficacy review | 0 | 10 |
What does 'FDA registered' actually mean?
That a facility filed a registration with the agency. It is not approval, it is not an endorsement, and it says nothing about any particular product. The same applies to 'FDA inspected', which means an inspection occurred rather than that it went well.
These phrases appear in compounded-product marketing precisely because they sound like approval. Reading them accurately is one of the more useful skills a buyer in this market can have.
| Term | What it means | What it does not mean |
|---|---|---|
| FDA approved | Safety, efficacy and quality reviewed before marketing | Applies to any compounded preparation |
| FDA registered | The facility filed a registration | The product was reviewed or approved |
| FDA inspected | An inspection occurred | The inspection found no problems |
| State licensed | A board authorised the pharmacy to operate | Any federal review of the product |
| cGMP compliant | The facility follows manufacturing practice standards | The specific product was evaluated |
| Third-party tested | A laboratory analysed a sample | Systematic batch verification |
What is the honest limit of these checks?
They reduce risk without eliminating it. Verifying a licence establishes that a pharmacy is authorised to operate; it does not establish the quality of any particular preparation, and no check available to a consumer substitutes for the premarket review an approved product undergoes.
That residual uncertainty is a real cost of the compounded route rather than something a checklist dissolves — and it is a larger cost now than it was two years ago.
What would change the conclusion on this page?
Any of the following would change what this page concludes:
- New primary evidence bearing directly on verify compounding pharmacy tirzepatide.
- A change to FDA labelling or regulatory position affecting a statement above.
- A verified correction accepted through the corrections process.
- A material change to a captured price, term, or programme condition.
More from the journal: all pieces
What are the limits of what this page can tell you?
Every page on this site rests on a specific published evidence, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for a qualified professional.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
This page would be revised, with the change recorded in its history, if any of the following occurred:
- New primary evidence bearing directly on how to verify a pharmacy now that the shortage rules have changed.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
What do the technical terms on this page mean?
Definitions for the 5 technical terms this page uses, including 503A, 503B, beyond-use date, compounded — in the specific sense used above.
| 503A | A pharmacy that compounds patient-specific preparations against individual prescriptions. It is licensed by a state board of pharmacy and is not subject to the same federal manufacturing requirements as a 503B facility. |
|---|---|
| 503B | An outsourcing facility that may compound in larger batches without individual prescriptions. It registers with the FDA and is subject to current good manufacturing practice requirements, though registration is still not product approval. |
| beyond-use date | The date after which a compounded preparation should not be used. It is assigned by the compounding pharmacy based on its own conditions, and is typically much shorter than a manufacturer expiry date derived from formal stability testing. |
| compounded | Prepared by a pharmacy rather than manufactured under an approved application. Compounded tirzepatide is not FDA approved and has not been evaluated in any randomised trial. |
| mg/mL | Milligrams of drug per millilitre of liquid — the concentration. Two vials containing the same nominal dose can require different injection volumes if their concentrations differ, which is why this site does not publish volume calculations. |
Frequently asked questions
How do I check if a compounding pharmacy is licensed?
Search the licensing state board of pharmacy's public register for the pharmacy's legal name.
Does 'FDA registered' mean the product is approved?
No. Registration is a facility filing and says nothing about any particular product.
What is the difference between 503A and 503B?
503A pharmacies compound patient-specific preparations against individual prescriptions; 503B outsourcing facilities may compound in batches and register with the FDA.
Should I be more cautious now than in 2024?
Yes. Continued supply of compounded tirzepatide now rests on a contested legal argument.
Is any pharmacy verified on this site?
No. Pharmacy fields are marked pending for all 24 providers rather than inferred.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.